Skip to content

Endocard Pacin Lead-Std Length PL100

by Daig Corp. 510(k)

Active United States

510(k) K771564

Overview

This device is a Permanent Pacemaker Electrode, designed for endocardial pacing. It delivers electrical stimulation to the heart muscle to regulate cardiac rhythm in patients with bradycardia or conduction disorders, ensuring proper heart function through consistent pacing signals.

The Endocard Pacin Lead-Std Length PL100 is supplied sterile and intended for single-use implantation. It is classified as a Class III device under FDA regulations and requires traditional 510(k) clearance. The lead is intended for use in cardiac electrophysiology procedures, adhering to MRI safety guidelines for pacemaker electrodes. Storage and handling must comply with sterile medical device protocols.

AI-generated from registry data, 18 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK771564 Date14 Sep 1977ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Other devices from Daig Corp.

See all devices from Daig Corp. →

Questions

  • What is the primary purpose of the ENDOCARD. PACIN/ LEAD-STD. LENGTH PL100 device, and how does it function in a clinical setting?

    The ENDOCARD. PACIN/ LEAD-STD. LENGTH PL100 is a permanent pacemaker electrode designed for endocardial pacing, meaning it delivers electrical impulses directly to the heart muscle to maintain a proper heart rhythm. It is used in patients with bradycardia (slow heart rate) or conduction disorders, ensuring consistent pacing signals to regulate cardiac function. The lead is implanted during cardiac electrophysiology procedures and works in conjunction with a pacemaker to stimulate the heart when natural electrical signals are insufficient.

  • Is this device intended for reuse, or is it meant to be used only once after implantation?

    This device is sterile and intended for single-use only. It is not designed for reuse, and proper sterile medical device protocols must be followed during handling and implantation to ensure patient safety.

  • What storage and handling precautions should be taken with the ENDOCARD. PACIN/ LEAD-STD. LENGTH PL100?

    Since this is a sterile, single-use device, it must be stored and handled according to sterile medical device protocols to prevent contamination. The packaging should remain intact until use, and any exposure to non-sterile environments should be avoided. Follow manufacturer guidelines for shelf life and storage conditions to maintain device integrity.

  • Does this device comply with MRI safety guidelines, and how should it be considered in a clinical setting involving magnetic resonance imaging?

    Yes, this device adheres to MRI safety guidelines for pacemaker electrodes, meaning it is designed with considerations for compatibility with MRI procedures. However, clinical protocols must still be followed carefully, as MRI use with pacemaker leads carries risks. Always consult the manufacturer’s instructions and local MRI safety guidelines before exposing the patient to MRI environments.

  • What regulatory pathway was followed for this device, and what does that mean for its use in clinical practice?

    This device was cleared through the FDA’s 510(k) pathway, specifically a Traditional 510(k) submission, and is classified as a Class III medical device. This means it underwent a rigorous review by the FDA’s Cardiovascular (CV) Advisory Committee to demonstrate substantial equivalence to a legally marketed predicate device. Clinically, this indicates that the device has met FDA standards for safety and effectiveness, but practitioners should always refer to the latest labeling and guidelines for proper use.